The Patient Experience of Gout Remission: A Qualitative Study.

Adwoa Dansoa Tabi-Amponsah, Sarah Stewart, Graham Hosie, Anne Horne, Nicola Dalbeth
{"title":"The Patient Experience of Gout Remission: A Qualitative Study.","authors":"Adwoa Dansoa Tabi-Amponsah,&nbsp;Sarah Stewart,&nbsp;Graham Hosie,&nbsp;Anne Horne,&nbsp;Nicola Dalbeth","doi":"10.1002/acr2.11579","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Preliminary remission criteria for gout have been developed. However, the patient experience of gout remission has not been described. This qualitative study aimed to understand the patient experience of gout remission and views about the preliminary gout remission criteria.</p><p><strong>Methods: </strong>Semistructured interviews were conducted. All participants had gout, had not had a gout flare in the preceding 6 months, and were on urate-lowering medication. Participants were asked to discuss their experience of gout remission and views about the preliminary remission criteria. Interviews were audio recorded and transcribed verbatim. Data were analyzed using a reflexive thematic approach.</p><p><strong>Results: </strong>Twenty participants with gout (17 male participants, median age 63 years) were interviewed. Four key themes of the patient experience of remission were identified: 1) minimal or no gout symptoms (absence of pain due to gout flares, good physical function, smaller or no tophi), 2) freedom from dietary restrictions, 3) gout is \"not on the mind\", and 4) multifaceted management strategies to maintain remission (regular urate-lowering therapy, exercise, healthy eating). Participants believed that the preliminary remission criteria contained all relevant domains but considered that the pain and patient global assessment domains overlapped with the gout flares domain. Participants regarded 12 months as a more suitable time frame than 6 months to measure remission.</p><p><strong>Conclusion: </strong>Patients experience gout remission as a return to normality with minimal or no gout symptoms, dietary freedom, and absence of mental load. Patients use a range of management strategies to maintain gout remission.</p>","PeriodicalId":7084,"journal":{"name":"ACR Open Rheumatology","volume":"5 8","pages":"399-406"},"PeriodicalIF":0.0000,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/33/39/ACR2-5-399.PMC10425584.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACR Open Rheumatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/acr2.11579","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Preliminary remission criteria for gout have been developed. However, the patient experience of gout remission has not been described. This qualitative study aimed to understand the patient experience of gout remission and views about the preliminary gout remission criteria.

Methods: Semistructured interviews were conducted. All participants had gout, had not had a gout flare in the preceding 6 months, and were on urate-lowering medication. Participants were asked to discuss their experience of gout remission and views about the preliminary remission criteria. Interviews were audio recorded and transcribed verbatim. Data were analyzed using a reflexive thematic approach.

Results: Twenty participants with gout (17 male participants, median age 63 years) were interviewed. Four key themes of the patient experience of remission were identified: 1) minimal or no gout symptoms (absence of pain due to gout flares, good physical function, smaller or no tophi), 2) freedom from dietary restrictions, 3) gout is "not on the mind", and 4) multifaceted management strategies to maintain remission (regular urate-lowering therapy, exercise, healthy eating). Participants believed that the preliminary remission criteria contained all relevant domains but considered that the pain and patient global assessment domains overlapped with the gout flares domain. Participants regarded 12 months as a more suitable time frame than 6 months to measure remission.

Conclusion: Patients experience gout remission as a return to normality with minimal or no gout symptoms, dietary freedom, and absence of mental load. Patients use a range of management strategies to maintain gout remission.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
痛风缓解的患者体验:一项定性研究。
目的:初步制定痛风缓解标准。然而,痛风缓解的患者经验尚未被描述。本定性研究旨在了解患者痛风缓解的经历和对痛风初步缓解标准的看法。方法:采用半结构化访谈法。所有的参与者都有痛风,在之前的6个月内没有痛风发作,并且正在服用降尿酸药物。参与者被要求讨论他们痛风缓解的经历和对初步缓解标准的看法。采访录音并逐字抄写。数据分析采用反身性专题方法。结果:20名痛风患者(17名男性,中位年龄63岁)接受了访谈。确定了患者缓解经历的四个关键主题:1)最小或没有痛风症状(由于痛风发作而没有疼痛,身体功能良好,痛风较小或没有痛风石),2)不受饮食限制,3)痛风“不在心上”,4)多方面的管理策略来维持缓解(定期降尿酸治疗,运动,健康饮食)。参与者认为初步缓解标准包含所有相关领域,但认为疼痛和患者整体评估领域与痛风耀斑领域重叠。参与者认为12个月比6个月更适合衡量缓解。结论:患者经历痛风缓解作为恢复正常最小或没有痛风症状,饮食自由,精神负荷的缺失。患者使用一系列的管理策略来维持痛风缓解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Redox Pathogenesis in Rheumatic Diseases. Treatment for Rheumatoid Arthritis Associated With Alterations in the Gastrointestinal Microbiota. CD14+ Dendritic-Shaped Cells Functioning as Dendritic Cells in Rheumatoid Arthritis Synovial Tissues. Patient-Led Urate Self-Monitoring to Improve Clinical Outcomes in People With Gout: A Feasibility Study. Detection and Grading of Radiographic Hand Osteoarthritis Using an Automated Machine Learning Platform.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1